Inhibitors of RIPK2 and medical uses thereof
AssigneeOdyssey Therapeutics, Inc.
InventorsChad VanHuis, Shifeng Pan, Dominik K. Koelmel, Robert Aversa, Clarke Taylor, Marta Wlodarska
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to RIPK2 inhibitors represented by structural formula (I): The disclosure further relates to pharmaceutical composition comprising the RIPK2 inhibitors and methods of treatment of conditions such as inflammatory diseases, autoimmune diseases, granulomatous disease, neurodegenerative disease, and cancer.
Claims11
A compound represented by the following structural formula:
- or a pharmaceutically acceptable salt thereof.
A method of treating inflammatory bowel disease (IBD), comprising administering to a subject in need thereof a therapeutically effective amount of a compound represented by the following structural formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.